Pregnancy and congenital heart disease

British Medical Journal

Volumn 332, Issue 7538, 2006, Pages 401-406

  Uebing, Anselm ^a   Steer, Philip J ^b   Yentis, Steve M ^b   Gatzoulis, Michael A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMILORIDE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; FLECAINIDE; HEPARIN; LIDOCAINE; MEXILETINE; PROCAINAMIDE; QUINIDINE; WARFARIN; CARDIOVASCULAR AGENT; ORAL CONTRACEPTIVE AGENT;

CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTRACEPTION; DELIVERY; HUMAN; LIFE EXPECTANCY; MATERNAL CARE; PARENT COUNSELING; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PROGENY; PUERPERIUM; REVIEW; RISK FACTOR; THROMBOEMBOLISM; UNITED KINGDOM; CONGENITAL HEART MALFORMATION; COUNSELING; DRUG CONTRAINDICATION; FEMALE; FETUS DISEASE; HIGH RISK PREGNANCY; INDUCED ABORTION; METHODOLOGY; POSTNATAL CARE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RECURRENT DISEASE;

ABORTION, INDUCED; ANTICOAGULANTS; CARDIOVASCULAR AGENTS; CONTRACEPTIVES, ORAL; COUNSELING; FEMALE; FETAL DISEASES; HEART DEFECTS, CONGENITAL; HUMANS; LIFE EXPECTANCY; POSTNATAL CARE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL CARE; RECURRENCE; RISK FACTORS;

EID: 33644860897     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38756.482882.de     Document Type: Review

References (25)

1. Nieminen HP, Jokinen EV, Sairanen HI. Late results of pediatric cardiac surgery in Finland: a population-based study with 96% follow-up. Circulation 2001;104:570-5.
2. Thorne S, Deanfield J. Long-term outlook in treated congenital heart disease. Arch Dis Child 1996;75:6-8.
3. Wren C, O'Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart 2001;85:438-43.
4. Lewis G, Drife JO. Why mothers die 2000-2002-The sixth report of confidential enquiries into maternal deaths in the United Kingdom. London; RCOG Press, 2004.
5. Thorne SA. Pregnancy in heart disease. Heart 2004;90:450-6.
6. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81.
7. Gatzoulis MA. Adult congenital heart disease: education, education, education. Nat Clin Pract Cardiovasc Med 2006;3:2-3.
8. Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorensen S, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789-94.
9. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21.
10. Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84.
11. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673-6.
12. Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol 2001;98:427-33.
13. Nora JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994;23:1468-71.
14. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
15. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6.
16. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
17. Roberts N, Ross D, Flint SK, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin. BJOG 2001;108:327-9.
18. Ellison J, Thomson AJ, Walker ID, Greer IA. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis. BJOG 2001;108:757-9.
19. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 suppl):627-44S.
20. Elkayam U. Pregnancy through a prosthetic heart valve. J Am Coll Cardiol 1999;33:1642-5.
21. Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev 2004;12:201-21.
22. Qasqas SA, McPherson C, Frishman WH, Elkayam U. Cardiovascular pharmaco therapeutic considerations during pregnancy and lactation. Cardiol Rev 2004;12:240-61.
23. Steer PJ. Pregnancy and contraception. In: Gatzoulis MA, Swan L, Therrien J, Pantely GA, eds. Adult congenital heart disease: A practical guide. Oxford: BMJ Publishing, Blackwell Publishing, 2005:16-35.
24. Suntharalingam G, Dob D, Yentis SM. Obstetric epidural analgesia in aortic stenosis: a low-dose technique for labour and instrumental delivery. Int J Obstet Anesth 2001;10:129-34.
25. Lupton M, Oteng-Ntim E, Ayida G, Steer PJ. Cardiac disease in pregnancy. Curr Opin Obstet Gynecol 2002;14:137-43.